Sagimet Biosciences Inc.
SGMT
$10.55
$1.2713.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.95M | -10.65M | -9.57M | -12.91M | -10.39M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.71M | 1.74M | 2.03M | 2.03M | 1.41M |
| Change in Net Operating Assets | -859.00K | 301.00K | -4.29M | 701.00K | -125.00K |
| Cash from Operations | -11.10M | -8.61M | -11.83M | -10.18M | -9.10M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.02M | 10.22M | 14.36M | 75.00K | -13.29M |
| Cash from Investing | -24.02M | 10.22M | 14.36M | 75.00K | -13.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 175.19M | -- | 0.00 | 274.00K | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.80M | -- | -- | -- | -- |
| Cash from Financing | 164.39M | -- | 0.00 | 274.00K | 1.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 129.27M | 1.61M | 2.53M | -9.83M | -22.39M |